Prevalence and genetic profiling of virulence determinants of non-O157 Shiga toxin-producing Escherichia coli isolated from cattle, beef, and humans, Calcutta, India. (Research).
The first documented U.S. outbreak of diarrhea due to infection by Shiga toxin-producing Escherichia coli (STEC) belonging to the serotype O157:H7 occurred in 1982 (1). Since then, STEC has been increasingly recognized as an important human diarrheal pathogen and as the predominant cause of hemorrhagic colitis and hemolytic uremic syndrome (HUS). STEC is now being detected in 75% to 100% of episodes of sporadic HUS in Europe, North America, Canada, and Latin America, especially Argentina (2).
Multiple virulence factors contribute to the pathogenicity of STEC. Its main pathogenic property is the production of Shiga toxin (Stx), which inhibits the protein synthesis of host cells leading to cell death (3,4). E. coli Stxs are classified into two types, Stx1 and Stx2, and each type has several variants. Stx1 and Stx2 are encoded by alleles in the genome of temperate, lambdoid bacteriophages that remain integrated in the E. coli chromosome (5). The strains carry in their chromosome a 35-kb pathogenicity island called locus of enterocyte effacement (LEE), whose genes are responsible for generation of attachment and effacement lesions. LEE encodes a type III secretion system, and some LEE genes are necessary for initiation of signal transduction events (6). However, not all STEC strains harbor the LEE, and it is not necessary to cause human infection. Moreover, STEC strains almost invariably harbor a 97-kb plasmid encoding possible additional virulence traits such as STEC hemolysin (which acts as a pore-forming cytolysin on eukaryotic cells ); the bifunctional catalase peroxidase KatP (8); a secreted serine protease (espP, which can cleave human coagulation factor V ); and the etpD gene cluster (which probably encodes a type II secretion pathway [10, 11]).
Cattle and sheep are the primary reservoirs of STEC, but STEC has been isolated from deer, horses, dogs, and birds (12). Feces from any of these animals could serve as primary source for STEC. The dynamics of these pathogens in animals and environment is not well understood. Principally, STEC is transmitted through the consumption of contaminated foods such as raw or undercooked ground meat products and raw milk (13). Although cattle are the primary known reservoirs of STEC, humans may acquire STEC infections from other sources, possibly vegetables (14), fruit juice (15), or contaminated drinking water (16), or through direct contact with feces of infected persons (17).
In industrialized countries such as the United States, Japan, Germany, Australia, and United Kingdom, large outbreaks and many sporadic cases of STEC infections have been reported and have become a major health concern. More than 50 serotypes types of STEC have been isolated from stool samples of patients with hemorrhagic colitis or HUS; however, many of these serotypes have not been as thoroughly or systematically characterized for virulence genes and properties as Escherichia coli O157:H7. To date, very few isolates of STEC from humans or animals have been reported in industrialized countries.
In India, there is a paucity of information on STEC. It has not been identified as an etiologic agent of diarrhea in India. Though a few strains of O157 serogroup have been isolated from sporadic cases of diarrhea, these strains have not been well characterized, and their origin is uncertain (18).
Serotyping of STEC alone is insufficient to assess the pathogenic properties of the strains because such organisms are quite variable in their repertoire of virulence determinants. Analysis of the genotypes of the STEC strains by the use of specific gene probes or polymerase chain reaction (PCR) provides more detailed information about genetic variability and subtypes (11).
In this study, we investigated the prevalence of STEC in healthy domestic cattle of a semi-urban community, in raw beef samples, and in hospitalized patients with diarrhea in Calcutta, India. Isolated STEC strains were characterized in detail to identify the predominant virulence genes and to understand how the Indian strains compare with STEC strains isolated elsewhere in the world.
Materials and Methods
Stool samples were collected from diarrheal patients enrolled in an ongoing active surveillance system at the Infectious Diseases Hospital (IDH) and from all the cases attending the B.C. Roy Hospital for Children, Calcutta, during a 1-year study period from January to December 1999. In the surveillance system, every fifth patient attending the hospital was included for sampling. Stool samples were collected in sterile McCartney bottles by using sterile catheters; sterile cotton-tipped swabs were used to take rectal swabs from patients from whom stool could not be obtained. Rectal swabs were placed in Cary-Blair medium, and stool samples were transported to the laboratory within 1 hour of collection. All samples were examined for STEC and other enteric pathogens such as other diarrheogenic E. coli, vibrios, Salmonella spp, Shigella spp, Aeromonas spp, rotavirus, parasites, and protozoans, following standard methods (19).
Cow Stool Samples
One hundred forty stool samples were collected from domestic cows of a semi-urban community near Calcutta; 66 stool samples were obtained from the state livestock farm at Kalyani, 71 kms away from Calcutta. These samples were collected at no defined periodicity during the year 1999.
A total of 111 beef samples were collected from Calcutta Municipal Corporation abattoir, situated in Tangra. Collections were made twice a month during March to July 1999, the season when the maximum number of diarrhea patients is admitted to IDH and other Calcutta hospitals.
Enrichment of Samples
A loopful of human or cow stool samples was directly inoculated into 3 mL of Bacto EC Medium (Difco, MI, USA) for enrichment and incubated overnight at 37 [degrees] C under shaking conditions. With beef samples, 50 mL of EC broth was aseptically transferred into a polythene bag and mixed well with the beef sample. After 2 hours, the broth was transferred into a sterile conical flask and incubated overnight at 37 [degrees] C with constant shaking. After overnight incubation, STEC was screened by using a variety of screening methods as described below.
Enrichment Broth PCR
After incubation, enriched broth was directly examined by PCR using stx1 and stx2 primers under the conditions described in Table 1. Broth cultures that yielded positive PCR results for either stx1 or stx2 or both were serially diluted in 10 mM phosphate-buffered saline (PBS) (pH 7.0) and 100 [micro]L volume of each dilution was spread on Luria agar (Difco) plate in duplicate. Randomly picked colonies were further screened for the presence of STEC by PCR or colony hybridization using DIG-labeled stx1 and stx2 gene probes as described below.
PCR Screening for Single-Cell Isolation
Single colonies were randomly picked from the dilution plates and spot inoculated on a master Luria agar plate and then inoculated in 3 mL EC broth. Four colonies were pooled for each EC broth and incubated overnight at 37 [degrees] C in a shaker. Attempts were made to inoculate as many colonies as possible from each plate. Following overnight incubation, the inoculated EC broth culture was diluted 10-fold with sterile PBS and boiled for 10 minutes. This method was used as the template for a multiplex PCR using primers for stx1 or stx2 genes (Table 1). PCR was done as described previously (20). When a positive PCR result was obtained, the PCR was repeated to determine which of the four pooled colonies contributed to the positive result. Once an STEC strain was identified, it was preserved in Luria broth supplemented with 15% glycerol at -70 [degrees] C.
Colony Hybridization for Single-Cell Isolation
An alternative approach adopted to identify STEC colonies from the dilution plates was the colony hybridization procedure, followed as described previously (11,23). Positive STEC colonies, if present, appeared as dark purple spots on the membrane. Colonies in the dilution plates were matched with the spots on the membrane, and isolated STEC strains were reconfirmed by PCR, as described. Probes used included fragments of stx1 (905 bp BamHI and EcoRI digest from recombinant plasmid pKTN501) (24) and stx2-A (860 bp BamHI and EcoRI digest from recombinant plasmid pKTN502) (25). These probes were also used for the dot blot assay, which employed PCR amplicons obtained from enrichment cultures of human stool, cow stool, and beef samples to confirm the PCR specificity.
Screening for Pathogenic Factors by PCR
PCR for detecting both chromosomal and plasmid virulence markers was performed by using a thermal cycler in a total volume of 20 [micro]L containing 2.5 mM of each deoxynucleoside triphosphate, 30 FM of each primer, 2 [micro]L of 10X PCR buffer, and 1 U of r-Taq DNA polymerase (both from Takara, Shuzo, Otsu, Japan). Primer sequences and PCR conditions are given in Table 1.
Screening for Pathogenic Factors by Colony Hybridization
A colony hybridization test for detecting pathogenic factors was carried out as described previously (26). DNA probes for espP, katP, eae, and hlyA were prepared by PCR. Primer sequences and PCR conditions are given in Table 2. After PCR, the products were purified by QIA Quick PCR Purification Kit (QIAGEN GmbH, Germany) in accordance with the manufacturer's instructions. The DNA probes were labeled by random priming method using Multiprime DNA labeling system and [[[alpha].sup.32]P] dCTP, and the colony hybridization procedure was followed as described (23).
Serotypes of the STEC strains were determined by slide agglutination with either commercially available O (poly and monovalent antisera) and H (monovalent antisera) (Denka Seiken Co., Japan) or antisera prepared at the Osaka Prefectural Public Health Institute, Osaka, Japan.
Vero Cell Assay
Preparation of Cell-Free Culture Filtrates
STEC strains were cultured in L-broth (Difco), at 37 [degrees] C overnight with constant shaking. Bacterial cells were pelleted by centrifugation at 12,000 rpm for 5 min at 4 [degrees] C. The supernatant was filter-sterilized by using 0.22-[micro]m filters (Millipore, USA). The culture pellet was resuspended in PBS and then sonicated by using a Handy sonic (Tomy Seiko Co, Ltd., Tokyo, Japan), which was again centrifuged to remove debris. Supernatant was filter-sterilized. Both the culture supernatant and cell lysate were used for the assay.
The cytotoxic effect of STEC strains was assayed on Vero cells in 96-well flat-bottom tissue culture plates (NUNC, Intermade, Denmark), as previously described (24). The cells were observed microscopically for 72 hours and the cytotoxicity titers determined; the highest toxin dilution that caused lysis of 50% of the cell monolayer was taken as the titer.
The initial procedure for preparation of cell-free culture supernatant and cell lysate was the same as for the Vero cell assay. The procedure for the bead ELISA has been described (23).
Hemolytic activity of the STEC strains was investigated by streaking the strains on tryptic soy agar (Difco) plates containing 5% washed and unwashed O group human blood cells. The hemolytic activity was observed from 3 to 18 hrs of incubation at 37 [degrees] C (11).
Prevalence of STEC in Human Stool Samples
The age distribution of the 1,241 and 284 patients whose samples were examined from IDH and B.C. Roy Hospital for Children, respectively, is shown in Table 3. Of the specimens from IDH patients during the period of surveillance, eight were positive for STEC by PCR in the preliminary screening. However, only nine strains could be isolated from six of the eight PCR-positive samples. The strains AK-11 and AK-26 were isolated from the same stool sample; AK-27, AK-28, and AK-29 were isolated from another single stool sample. Four of the 284 bloody stool samples examined from B.C. Roy Memorial Hospital for Children were positive for STEC by PCR, but again STEC could be isolated from only 3 of the 4 PCR-positive samples. Of note, 7 (58%) of 12 diarrhea patients from whom STEC was isolated were also co-infected with other pathogens (Table 4). STEC was isolated as the sole pathogen from 5 (42%) of 12 patients with diarrhea. The relative frequency of other enteric pathogens detected in the study samples is shown in Table 5.
Prevalence of STEC in Beef Samples
Of the 111 raw beef samples examined, 55 samples were positive for STEC when examined by multiplex PCR for stx1 or stx2. However, STEC was isolated from only 4 of the 55 PCR-positive samples by using the techniques adopted in this study.
Prevalence of STEC in Cow Stool Samples
Eight of 140 stool samples from cows examined from the community were positive for STEC; 10 STEC strains were recovered from the 8 samples. In contrast, of the 66 cow stool samples collected from Kalyani farm, STEC was detected in 29 by PCR. Only 5 strains could be isolated from the 29 PCR-positive samples.
Of the 30 STEC strains isolated in this study, 8 strains were O antigen untypable with somatic (O) antiserum. However, except for one strain (AK-32), all the O-untypable strains were typable with different H-types (Table 6). Of the strains typed, four belonged to serotypes that are not listed in the updated list of serotypes of non-e157 STEC isolated from humans worldwide (http://www.microbionet.com.au/frames/feature/vtec/ brief01.html). These are O96:H19, ONT:NM, ONT:H18, and ONT:H14. There was no clustering of any particular serotype. The serotypes ONT:H19 and O159:H12 were isolated from both humans and cows; otherwise, there was no match between serotypes of STEC isolated from human, cow, and beef samples (Table 6).
Analysis of Chromosomal Markers
stx1 and stx2
In our study, 30 strains were positive for stx by PCR. Of the 12 human isolates, 7 were positive for only stx1, 2 for only stx2, and 3 for both stx1 and stx2 (Table 6). Of the 14 strains isolated from cow stool samples, 6 carried stx1; 3, stx2; and 5 were positive for both stx1 and stx2. Three of the four strains isolated from raw beef harbored stx1 and stx2; the fourth carried only stx1.
As in the case of enteropathogenic E. coli (EPEC), the characteristic attaching and effacing (A/E) ability is encoded by 41 genes present on the LEE pathogenicity island (6,27). Pathogenicity of STEC is associated with the presence of LEE and in particular eae. We performed PCR with primers EAE-1 and EAE-2. An 863-bp PCR product was demonstrated for four strains (P-33-2-26, AK-16, AK-38, and AK-40), indicating the presence of eae (Table 6).
Analysis of Plasmid-Encoded Markers
E-hly, etpD, katP, and espP are plasmid-encoded markers. PCR with the hemolysin primers hlyA1 and hlyA4 showed that 12 of the 30 STEC isolates contained E-hly sequences. However, AK-1, although negative by PCR, hybridized with hlyA probe (Table 6). The remaining strains were negative. However, P-33-2-26 and AK-38 produced a PCR product of 1062 bp, and primers D1 and D13R suggested the presence of etpD gene cluster. Seven strains possessed the katP gene cluster, as demonstrated by PCR with primers pair wkatB and wkatF as well as by colony hybridization. While espP could be detected in 11 strains when analyzed by probe complementary to espP sequence, only 2 strains generated the specific amplicon when PCR was carried out with espP-specific primer.
Thus, the analysis of virulence markers revealed that in the present collection of strains AK-38, a cow stool isolate not belonging to the O157 serogroup carried all the potential virulence genes.
Phenotypic Characterization of STEC Strains
Vero Cell Assay
Expression of Stx was examined by Vero cell cytotoxic assay. Of the 30 strains examined, all were cytotoxic to the Vero cells. AK-38, despite having stx1 and the full repertoire of virulence genes, did not exhibit the cytotoxic effect (Table 6).
A highly sensitive bead-ELISA was applied to detect the presence of Stx1 and Stx2 in the cell-free culture filtrate and cell lysate of the isolates in this study. This assay identified Stx1 in 12 of 14 stx1 PCR-positive strains but identified only 3 of the 5 stx2 PCR-positive strains in both cell filtrate and lysate. Of the 11 strains positive for stx1 and stx2 by PCR, 8 were positive by Bead-ELISA for both toxins (Table 6).
Fourteen of the thirty STEC isolates showed a hemolytic phenotype that resembled alpha-hemolytic activity rather than the typical enterohemolytic phenotype (Table 6). The zone was clear, large, and could be visualized after 3 to 18 hours' incubation at 37 [degrees] C. Of the 14 strains, 9 were positive by PCR using E-hlyA primer pair. However, three other STEC, which carried the hlyA gene, did not produce hemolysin.
During the past decade, STEC has evolved from a clinical novelty to a global public health concern. STEC infections have been reported from over 30 countries on six continents, causing a spectrum of human illness ranging from symptom-free carriage to severe bloody diarrhea and even to life-threatening sequelae such as HUS. However, there is a paucity of reports on STEC in the developing world including India. A previous study in India found no STEC in children with diarrhea in Delhi (28); a study from Bangladesh reported that no STEC were recovered from children with diarrhea (29). This is possibly related to lack of surveillance for this organism because of the difficulty in isolating STEC. However, in an outbreak of bloody diarrhea in Cameroon, half the patient specimens yielded STEC and half Shigella species (30).
We attempted to document the prevalence of STEC in Calcutta and provide information on the phenotypic traits, serotypes, and molecular characterization of the virulence genes. The reasons for the low prevalence of STEC-associated diarrhea in Calcutta and possibly other places in India are not well understood. Perhaps Indians acquire protective antibodies at an early age or use cooking practices that effectively eliminate STEC.
The isolation rate of STEC from hospitalized secretory and bloody diarrhea cases was very low in this study, and there was no evidence of a seasonal distribution of STEC-positive samples. Among STEC-identified diarrhea cases, 58% were found to be infected with other enteric pathogens. One case was positive for Vibrio parahaemolyticus, STEC, and Shigella. In such situations, it is difficult to conclude the role played by STEC in causing disease. We included religion in the data analysis since the food habits of Hindus and Muslims vary (e.g., Muslims eat beef) (Table 3). Indirect routes of transmission may, however, be more significant in India, where most of the population does not eat beef for religious reasons. Possibly in areas like this, STEC transmission could occur through exposure to vegetables, fruits, or drinking water contaminated by bovine feces or through direct contact with feces of infected persons (14-17). Only non-O157 STEC strains were isolated from human cases. In general, with the exception of North America and Japan, non-O157 STEC strains are isolated more frequently than O157, with a median of a fourfold higher isolation rate but with wide variation among studies (31). From our intense survey conducted over a 1-year period, it was clear that STEC are not currently a major diarrhea-causing etiologic agent in India. However, this study indicates that strains of E. coli with the O157 lipopolysaccharide and non-O157 LPS are present in the milieu, as are virulence genes, which are known to contribute to STEC virulence. Mixing and matching of genes in the environment or in the human intestine could lead to the evolution of pathogenic STEC.
The prevalence of STEC in bovine fecal flora and beef was high, according to PCR results. The occurrence of STEC in raw beef samples strongly indicates that unhygienic practices prevailed in slaughterhouses in Calcutta. Therefore, STECs are clearly present in beef and, as in other countries (12), there is a bovine reservoir of STEC in India. Isolation of twelve O157:H7 strains from 9 of 25 beef samples originally imported from India and sold in retail stores in Malaysia has recently been reported (32). However, STEC strains have not been able to cycle from contaminated food items or bovine reservoirs to humans. It is not certain whether the STEC strains in India lack some factor that is essential for them to become a frequent cause of diarrhea or whether this phenomenon is related to an as-yet-unidentified host factor.
There was a disparity in the ability to culture STEC from PCR-positive specimens. STEC was cultured from 75% of PCR-positive human stools and 100% of community cows, but we isolated STEC from only 17.2% of PCR-positive cows from the livestock farm and 7.3% of PCR-positive raw beef samples. One reason for these varying results could relate to the initial numbers present in the sample. We presume that the number of strains present in human diarrhea cases (where the causative agent is amplified) would be higher than that found in fecal samples of cows and raw beef samples. However, we cannot account for the 100% isolation from community cows. We plan to investigate this further. One of the reasons for the failure to isolate STEC strains was the frequent presence of swarming colonies, which tended to obliterate all other colonies. This happened despite increasing the agar concentration (3%) as well as 0.15% bile salts (for the inhibition of swarming colonies) in the Luria agar medium. To avoid false-positive PCR results, we confirmed that the PCR amplicons were specific for stx1 and stx2 by dot blot assay. We immobilized the PCR product on N+-nylon membrane and hybridized with stx1- and stx2-specific probes derived from pKTN501 and pKTN502, respectively, using the DIG-labeled kit. All PCR products gave positive signals in this hybridization assay, confirming that the PCR assay is specific for stx1 and stx2.
The inability to isolate STEC strains from PCR-positive samples might be due to the presence of very low numbers of the target strain. This appears to be one key reason for the rather low isolation rate of STEC despite its being present in the sample. Several previous studies have also reported difficulties in isolating the organism from stools of patients with HUS and hemorrhagic colitis. In one such study of HUS cases in which 20 individual colonies of E. coli from primary stool cultures were tested, the proportion of Stx-positive colonies varied from 5% to 20% (33). Moreover, many cases had free fecal Stx but no STEC were isolated (34). In those studies, we usually encountered swarming colonies in the plates assayed for STEC even after the addition of 3% agar and bile salts (0.15%). In the present study, we used three different procedures to isolate the STEC and O157 strains. We usually had to screen approximately 500 colonies to yield a positive PCR result in an attempt to isolate STEC. But since the frequency of occurrence of STEC is very low and since PCR is an expensive and laborious method for screening, we later opted for the colony hybridization-DIG procedure, which allows a greater number of colonies to be initially screened and therefore increases the probability of obtaining positive isolates.
The systematic analysis of virulence markers indicates that the STEC in Calcutta mostly contain stx1, whereas the eae gene occurs at low frequency among strains of human and bovine origin. Such low prevalence of eae in Calcutta strains is in contrast to a report from Germany, where eae was found in most STEC strains examined (11). PCR results revealed that hlyA was the most prevalent (43.3%) plasmid-encoded marker compared with katP (23.3%) and etpD (6.7%). With the espP gene, a considerable discrepancy was observed between the PCR and colony blot hybridization results. While 36.7% of strains were positive by colony blot hybridization, only 6.7% generated the desired amplicon with the espP primers. Comparison of the virulence profiles of Calcutta STEC strains isolated from different sources demonstrated the relative abundance of katP gene in cow and beef isolates (28.7% and 25%, respectively) compared with human strains (18.2%). Likewise, the percentage of hlyA PCR-positive STEC of bovine origin (64.3%) was more than twice that isolated from humans (27.3%). However, for the espP genes detected by colony hybridization, there was an appreciable variation in the distribution of this gene in strains isolated from cows (57.1%) and humans (18.2%). Two strains from cow stool samples were positive for etpD. Except for strains AK-40 and AK-38, nearly all Calcutta strains did not have the entire complement of virulence genes and therefore may not have been associated with diarrhea.
The observation that one stx2-positive strains showed cytotoxic effect on Vero cells but yielded negative Bead-ELISA result indicates that the toxin produced by this strain was antigenically different and may constitute a new variant of Stx2. Except for one strain, the other eight hlyA-positive STEC strains did not show the hemolytic phenotype when streaked on blood agar plates. One reason may be that the hemolysin of these strains remains cell associated because of a deficient transport system for secretion of hemolysin. Interestingly, one STEC strain AK-38 had all the known virulence markers of STEC but still gave a negative result in the Vero cell cytotoxicity assay. Based on the negative results obtained in BeadELISA and hemolysin assays, we presume that both stx1 and hlyA genes of this strain (AK38) might be silent. Another possibility is that additional DNA is present in this isolate close to the stx gene, which would presumably prevent expression of stx1 (11). Taken together, our analysis of non-O157 STEC strains suggests that pathogenicity is a consequence of lineal descent. The mere possession of stx genes is probably inadequate to render an E. coli pathogenic; an assortment of traits no doubt contributes to virulence, and the appropriate constellation of virulence traits appears to be present only in selected lineages.
In conclusion, this survey showed that STEC strains could not be implicated as a major causal agent of diarrhea but are present in the food chain in Calcutta. What exactly will trigger such strains to cause outbreaks is unclear. Given that STEC are present in the food chain in Calcutta and that STEC are not currently important human enteropathogens there, it would be useful to trace the natural history of the organism, should they become important enteropathogens in the not-too-distant future.
Table 1. Polymerase chain reaction (PCR) primers and conditions used in this study Primer no. Nucleotide sequence of primers Target EVT1/ 5'-CAACACTGGATGATCTCAG-3' EVT2 5'-CCCCCTCAACTGCTAATA-3' Stx1 family EVS1/ 5'-ATCAGTCGTCACTCACTGGT-3' EVC2 5'-CTGCTGTCACAGTGACAAA-3' Stx2 family hlyA1/ 5'-GGTGCAGCAGAAAAAGTTGTAG-3' hlyA4 5'-TCTCGCCTGATAGTGTTTGGTA-3' EHEC hlyA wkat-B/ 5'-CTTCCTGTTCTGATTCTTCTGG-3' wkat-F 5'-AACTTATTTCTCGCATCATCC-3' katP D1/ 5'-CGTCAGGAGGATGTTCAG-3' D13R 5'-CGACTGCACCTGTTCCTGATTA-3' etpD EAE1/ 5'-AAACAGGTGAAACTGTTGCC-3' EAE2 5'-CTCTGCAGATTAACCTCTGC-3' eae PCR conditions (a) Primer no. Denaturing Annealing Extension EVT1/ EVT2 94 [degrees] C, 55 [degrees] C, 72 [degrees] C, 60s 60s (b) 60s EVS1/ EVC2 94 [degrees] C, 55 [degrees] C, 72 [degrees] C, 60s 60s (b) 60s hlyA1/ hlyA4 94 [degrees] C, 57 [degrees] C, 72 [degrees] C, 30s 60s 90s wkat-B/ wkat-F 94 [degrees] C, 56 [degrees] C, 72 [degrees] C, 30s 60s 15s D1/ D13R 94 [degrees] C, 52 [degrees] C, 72 [degrees] C, 30s 60s 70s EAE1/ EAE2 94 [degrees] C, 55 [degrees] C, 72 [degrees] C, 60s 90s 90s Amplicon Primer no. (bp) References EVT1/ EVT2 349 20 EVS1/ EVC2 110 20 hlyA1/ hlyA4 1,551 7 wkat-B/ wkat-F 2,125 9 D1/ D13R 1,062 21 EAE1/ EAE2 350 22 (a) Unless stated, PCR was done for 30 cycles. (b) After 35 cycles, final extension step of 10 min at 72 [degrees] C was performed. Table 2. Polymerase chain reaction (PCR) primers and conditions for preparing DNA probes used in the colony hybridization test PCR conditions (a) Nucleotide sequence of primers Target Denaturing 5-GAGAATTCACAGATGGATATTTCAAATTTC-3 5-TCTCCTCGAGCTAGTTGACCTCGTTCAGAAACG-3 espP 94 [degrees] C, 10s 5-GAGAGAATTCTTCCTGTTCTGATTCTTCTG-3 5-TCTCCTCGAGTCAAAACTTATTTCTCGCATCATCATCC-3 katP 94 [degrees] C, 10s 5-TCTCAAGCTTTTAGAAATAGTCTCGCCAGTATTC-3 5-GAGAGAATTCGTCAGGAGGATGTTCAGG-3 eae 94 [degrees] C, 10s 5-GAGAGGATCCGGTGCAGCAGAAAAAGTTGTA-3 5-TCTCCTCGAGTCATCTCGCCTGATAGTGTTTGG-3 hlyA 94 [degrees] C, 10s PCR conditions (a) Nucleotide sequence of primers Annealing Extension 5-GAGAATTCACAGATGGATATTTCAAATTTC-3 5-TCTCCTCGAGCTAGTTGACCTCGTTCAGAAACG-3 68 [degrees] 72 [degre- C, 30s es] C, 90s 5-GAGAGAATTCTTCCTGTTCTGATTCTTCTG-3 5-TCTCCTCGAGTCAAAACTTATTTCTCGCATCATCATCC-3 68 [degrees] 72 [degre- C, 30s es] C, 60s 5-TCTCAAGCTTTTAGAAATAGTCTCGCCAGTATTC-3 5-GAGAGAATTCGTCAGGAGGATGTTCAGG-3 68 [degrees] 72 [degre- C, 30s es] C, 90s 5-GAGAGGATCCGGTGCAGCAGAAAAAGTTGTA-3 5-TCTCCTCGAGTCATCTCGCCTGATAGTGTTTGG-3 68 [degrees] 72 [degre- C, 30s es] C, 60s Nucleotide sequence of primers Amplican (bp) 5-GAGAATTCACAGATGGATATTTCAAATTTC-3 5-TCTCCTCGAGCTAGTTGACCTCGTTCAGAAACG-3 2,900 5-GAGAGAATTCTTCCTGTTCTGATTCTTCTG-3 5-TCTCCTCGAGTCAAAACTTATTTCTCGCATCATCATCC-3 2,130 5-TCTCAAGCTTTTAGAAATAGTCTCGCCAGTATTC-3 5-GAGAGAATTCGTCAGGAGGATGTTCAGG-3 880 5-GAGAGGATCCGGTGCAGCAGAAAAAGTTGTA-3 5-TCTCCTCGAGTCATCTCGCCTGATAGTGTTTGG-3 1,560 (a) PCR was done for 30 cycles. Table 3. Age distribution of patients admitted to hospitals where stool samples were examined Infectious Diseases B.C. Roy Hospital Age (in years) Hospital (%) for Children (%) [less than or equal to] 5 25.1 97.6 >5-15 10.1 2.4 >15-25 20.2 -- >25-35 18.0 -- >35-45 11.0 -- >45-55 7.6 -- >55 8.1 -- Table 4. Clinical manifestation and other information on patients from whom Shiga toxin-producing Escherichia coil was isolated Clinical manifestation STEC strain Stool Age number characteristics (years) Sex Religion Vomiting AK-11 (a) AK-26 (a) Watery 32 M H Negative None Watery 28 F MU Positive None Watery 17 F H Positive AK-18 Watery 30 M H Positive AK-27 (a) AK-28 (a) AK-29 (a) Watery 50 M O Positive AK-31 Watery 2 M H Positive AK-32 Watery 40 F O Negative AK-33 Watery 27 M MU Positive AK-14 Bloody 2 1/2 M MU Negative AK-30 Bloody 2 F MU Negative AK-40 Bloody 1 1/2 F MU Negative Clinical manifestation STEC strain Other pathogen(s) present number Fever Dehydration in the stool samples AK-11 (a) AK-26 (a) Negative Severe Vibrio parahaemolyticus None Positive No None None Positive Moderate None AK-18 Positive Severe V. cholerae O139 AK-27 (a) AK-28 (a) AK-29 (a) Positive Severe V. cholerae O1 AK-31 Negative Severe None AK-32 Negative Moderate V. cholerae non-O1 non-O139 AK-33 Positive No None AK-14 V. parahaemolyticus, Shigella Positive No spp. AK-30 Positive No None AK-40 Positive Moderate Shigella spp. (a) Strains isolated from one stool specimen but belonging to different serotypes. H, Hindu; MU, Muslim; O, Other religion; M, male; F, female. Table 5. Other enteropathogens isolated from stool samples examined for Shiga toxin-producing Escherichia coil, India Infectious Diseases B.C. Roy Hospital Enteropathogens Hospital (%) for Children Vibrio cholerae O1 9.5 0.6 O139 5.2 -- Non-O1 non-O139 3.7 3.1 Vibrio parahaemolyticus 2.8 0.4 Shigella flexneri 0.4 0.7 sonnei 0.1 -- boydii 0.2 -- Salmonella 0.5 1.1 E. coli EPEC 0.5 -- ETEC 1.3 -- EPEC, enteropathogenic Escherichia coil; ETEC, enterotoxigenic E. coli. Table 6. Serotype, phenotypic and genotypic traits of Shiga toxin-producing Escherichia coil strains, India Genotype (PCR/colony hybridization) Plasmid Strain no. Serotype Origin Chromosomal genes genes stx1 stx2 eae hlyA etpD AK-40 O11:H8 Human +/+ -/- +/+ +/+ -/- AK-11 ONT:H18 Human +/+ -/- -/- -/- -/- AK-18 O156:H7 Human +/+ -/- -/- -/- -/- AK-27 ONT:H19 Human +/+ -/- -/- -/- -/- AK-30 O7:H6 Human +/+ -/- -/- -/- -/- AK-32 ONT:NM Human +/+ -/- -/- -/- -/- AK-33 O159:H12 Human +/+ -/- -/- -/- -/- AK-26 O159:H9 Human -/- +/+ -/- -/- -/- AK-29 O110:H16 Human -/- +/+ -/- -/- -/- AK-14 ONT:H14 Human +/+ +/+ -/- +/+ -/- AK-28 O43:H2 Human +/+ +/+ -/- +/+ -/- AK-31 O96:H19 Human +/+ +/+ -/- -/- -/- P-33-2-26 ONT:H2 Cow +/+ -/- +/+ +/+ +/+ AK-38 O103:H2 Cow +/+ -/- +/+ +/+ +/+ P-179-101 O146:H1 Cow +/+ -/- -/- +/+ -/- C-45-3-19 O149:HNT Cow +/+ -/- -/- -/- -/- AK-35 O22:H16 Cow +/+ -/- -/- -/- -/- AK-39 O9B:H5 Cow +/+ -/- -/- -/- -/- C-5-1-13 O82:H8 Cow -/- +/+ -/- +/+ -/- AK-1 O2:H25 Cow -/- +/+ -/- -/+ -/- AK-37 O22:NM Cow -/- +/+ -/- +/+ -/- C-2-1-15 O28ac:H21 Cow +/+ +/+ -/- +/+ -/- C-3-2-25 ONT:H34 Cow +/+ +/+ -/- +/+ -/- C-3-3-42-6 ONT:H19 Cow +/+ +/+ -/- -/- -/- P-33-2-4 O88:HNT Cow +/+ +/+ -/- +/+ -/- AK-36 O159:H12 Cow +/+ +/+ -/- -/- -/- AK-16 ONT:H21 Beef +/+ -/- +/- -/- -/- AK-12 O20:H12 Beef +/+ +/+ -/- -/- -/- AK-13 O110:HNT Beef +/+ +/+ -/- -/- -/- AK-17 O172:NM Beef +/+ +/+ -/- +/+ -/- Genotype (PCR/colony hybridiza- tion) Plasmid Strain no. genes Phenotype katP espP Hemolysis SF (a) Vero (b) Stx1 Stx2 AK-40 +/+ -/+ E-hly + ND ND ND AK-11 -/- -/- E-hly + + + - AK-18 -/- -/- -- + + + - AK-27 +/+ -/- -- + + + - AK-30 -/- -/- -- + + + - AK-32 -/- -/- -- ND ND ND ND AK-33 -/- -/- E-hly + + + - AK-26 -/- -/- -- + + - + AK-29 -/- -/- -- + + - + AK-14 -/- -/+ E-hly + + + + AK-28 -/- -/- -- + + + + AK-31 -/- -/- -- ND ND ND ND P-33-2-26 +/+ -/- E-hly + + + - AK-38 +/+ -/- -- + - - - P-179-101 -/- -/+ E-hly + + + - C-45-3-19 -/- -/- -- + + + - AK-35 +/+ -/- -- + + + - AK-39 -/- +/+ E-hly + + + - C-5-1-13 -/- -/+ E-hly + + - + AK-1 +/+ -/- -- + + - - AK-37 -/- +/+ -- ND ND ND ND C-2-1-15 -/- -/+ E-hly + + + + C-3-2-25 -/- -/+ E-hly + + + + C-3-3-42-6 -/- -/+ E-hly + + + + P-33-2-4 -/- -/+ E-hly + + + + AK-36 -/- -/- E-hly + + + + AK-16 -/- -/- -- + + + - AK-12 -/- -/- ND + + + - AK-13 -/- -/- ND + + + - AK-17 +/+ -/+ E-hly + + + + (a) Fermentation of sorbitol. (b) Vero cell cytotoxicity. NT, Not typable; ND, Not determined; NM, nonmotile.
We are grateful to the director, Animal Resources Development Department, Government of West Bengal, India, and to the Epidemiology Division of National Institute of Cholera and Enteric Diseases, Calcutta, for their assistance in obtaining samples.
This research was supported by grants from the Human Science Foundation of Japan, Japan International Cooperation Agency (JICA/ NICED Project 054-1061-E-0), and the Council of Scientific and Industrial Research, New Delhi (27/EMR-II).
Mr. Asis Khan is a senior research fellow of the Indian Council of Medical Research. He is a doctoral student of Dr. G. Balakrish Nair, deputy director of the National Institute of Cholera and Enteric Diseases, Calcutta. Mr. Khan's research interests lie in the epidemiology of enteric pathogens.
(1.) Riley LW, Remis RS, Helgerson SD, McGee HB, Wells JG, Davis BR, et al. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med 1983;308:681-5.
(2.) Lopez EL, Contrini MM, De Rosa MF. Epidemiology of Shiga-toxin producing Escherichia coli in South America. In: Kaper JB, O'Brien AD, editors. Escherichia coli and other Shiga-toxin producing E. coli strains. Washington: American Society for Microbiology; 1998. p. 30-7.
(3.) O'Brien AD, Holmes RK. Shiga and Shiga-like toxin. Microbiol Rev 1987;1:206-20.
(4.) O'Brien AD, Tesh VL, Rolfe AD, Jackson MP, Olsnes S, Sandvig K, et al. Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis. Curr Top Microbiol Immunol 1992;180:65-94.
(5.) Strockbine NA, Marques LR, Newland JW, Smith HW, Holmes RK, O'Brien AD. Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities. Infect Immun 1986;53:135-40.
(6.) Kaper JB, Elliott S, Sperandio V, Pema NT, Mayhew GF, Blattner FR. Attaching and effacing intestinal histopathology and the locus of enterocyte effacement. In: Kaper JB, O'Brien AD, editors. Escherichia coli and other Shiga toxin-producing E. coli strains. Washington: American Society for Microbiology; 1998. p. 163-82.
(7.) Schmidt H, Beutin L, Karch H. Molecular analysis of the plasmid-encoded hemolysin of Escherichia coli O157:H7 strain EDL 933. Infect Immun 1995;63:1055-61.
(8.) Brunder W, Schmidt H, Karch H. KatP, a novel catalase-peroxidase encoded by the large plasmid of enterohaemorrhagic Escherichia coli O157:H7. Microbiology 1996;142:3305-15.
(9.) Brunder W, Schmidt H, Karch H. EspP, a novel extracellular serine protease of enterohaemorrhagic Escherichia coli O157:H7 cleaves human coagulation factor V. Mol Microbiol 1997;24:767-78.
(10.) Schmidt H, Henkel B, Karch H. A gene cluster closely related to type II secretion pathway operons of Gram-negative bacteria is isolated on the large plasmid of enterohemorrhagic Escherichia coli O157 strains. FEMS Microbiol Lett 1997;148:265-72.
(11.) Schmidt H, Geitz C, Phillips IT, Matthias F, Karch H. Non-O157 pathogenic shiga toxin producing Escherichia coli: phenotypic and genetic profiling of virulence traits and evidence for clonality. J Infect Dis 1999;179:115-23.
(12.) Beutin L, Geier D, Steinruck H, Zimmermann S, Scheutz F. Prevalence and some properties of verotoxin (Shiga-like toxin)-producing Escherichia coli in seven different species of healthy domestic animals. J Clin Microbiol 1993;31:2483-8.
(13.) Clark RC, Wilson JB, Read SC, Renwick S, Rahn K, Johnson P, et al. Vero cytotoxin producing Escherichia coli (VTEC) in the food chain: preharvest and processing perspectives. In: Karmali MA and Goglio AG, editors. Recent advances in verocytotoxin-producing Escherichia coli infections. Amsterdam: Elsevier Science B.V.; 1994. p. 17-24.
(14.) Hilborn ED, Mermin JH, Mshar PA, Hadler JL, Voetsch A, Wojtkunski C, et al. A multistate outbreak of Escherichia coli O157:H7 infections associated with consumption of mesclun lettuce. Arch Intern Med 1999;59:1758-64.
(15.) Cody SH, Glynn MK, Farrar JA, Cairns KL, Griffin PM, Kobayashi J, et al. An outbreak of Escherichia coli O157:H7 infection from unpasteurized commercial apple juice. Ann Intern Med 1999; 130:202-9.
(16.) Challmers RM, Aird H, Bolton FJ. Waterborne Escherichia coli O157. J Appl Microbiol 2000;88:124S-132S.
(17.) Renwick SA, Wilson JB, Clarke RC, Lior H, Borczyk AA, Spika J, et al. Evidence of direct transmission of Escherichia coli O157:H7 infection between calves and a human. J Infect Dis 1993;168:792-3.
(18.) Gupta S, Soni NK, Kaur P, Sood DK. Verocytopathic activity of Escherichia coli O157 and other "O" serogroups isolated from patients of diarrhea. Indian J Med Res 1992;95:71-6.
(19.) World Health Organization. Manual for laboratory investigation of acute enteric infections. Geneva: The Organization; 1983.
(20.) Pal A, Ghosh S, Ramamurthy T, Yamasaki S, Tsukamoto T, Bhattacharya SK, et al. Shiga-toxin producing Escherichia coli from healthy cattle in a semi-urban community in Calcutta, India. Indian J Med Res 1999;110:83-5.
(21.) Schmidt H, Henkel B, Karch H. A gene cluster closely related to type II secretion pathway operons of gram-negative bacteria is located on the large plasmid of enterohemorrhagic Escherichia coli O157 strains. FEMS Microbiol Lett 1997;148:265-72.
(22.) Yu J, Kaper JB. Cloning and characterization of the eae gene of enterohemorrhagic Escherichia coli O157:H7. Mol Microbiol 1992;6 411-7.
(23.) Yamasaki S, Lin Z, Shirai H, Terai A, Oku Y, Ito H, et al. Typing of verotoxins by DNA colony hybridization with poly- and oligonucleotide probes, a bead-enzyme-linked immunosorbent assay, and polymerase chain reaction. Microbiol Immunol 1996;40:345-52.
(24.) Kurazono H, Sasakawa C, Yoshikawa M, Takeda Y. Cloning of a Vero toxin (VT1, Shiga-like toxin 1) gene from a VT1-converting phage isolated from Escherichia coli O157:H7. FEMS Microbiol Lett 1987;44:236.
(25.) Ito H, Teral A, Kurazono H, Takeda Y, Nishibuchi M. Cloning and nucleotide sequencing of Vero toxin 2 variant genes from Escherichia coli O91:H21 isolated from a patient with hemolytic uremic syndrome. Microb Pathog 1990;8:47-60.
(26.) Moseley SL, Huq I, Alim ARMA, So M, Samadpour-Motalebi M, Falkow S. Detection of enterotoxigenic Escherichia coli by DNA colony hybridization. J Infect Dis 1980;142:892-8.
(27.) Oswald E, Schmidt H, Morabito S, Karch H, Marches O, Caprioli A. Typing of intimin genes in human and animal enterohemorrhagic and enteropathogenic Escherichia coli: Characterization of a new intimin variant. Infect Immun 2000;68:64-71.
(28.) Bhan M, Raj P, Levine MM, Kaper J B, Bhandari N, Srivastava R, et al. Enteroagggregative Escherichia coli associated with persistent diarrhoea in a cohort of rural children in India. J Infect Dis 1989;159:1061-4.
(29.) Albert M J, Faruque SM, Faruque ASG, Neogi PKB, Ansaruzzaman M, Bhuiyan NA, et al. Controlled study of Escherichia coli diarrheal infections in Bangladeshi children. J Clin Microbiol 1995;33:973-7.
(30.) Germani Y, Cunin P, Tedjouka E, bou Ncharre C, Morvan J, Martin P. Enterohaemorrhagic Escherichia coli in Ngoila (Cameroon) during an outbreak of bloody diarrhoea. Lancet 1998;352:625-6.
(31.) World Health Organization. Zoonotic non-O157 shiga toxin-producing Escherichia coli (STEC). Report of a WHO Scientific Working Group Meeting. WHO/CSR/APH/98.8. Geneva: The Organization; 1998. http:// www.who.int/emc.
(32.) Radu S, Mutalib SA, Rusel G, Ahmed Z, Morigaki T, Asea N, et al. Detection of Escherichia coli O157:H7 in the beef marketed in Malaysia. Appl Environ Microbiol 1998;64:1153-5.
(33.) Karmali MA, Martin P, Lim C, Fleming PC, Arbus GS, Lior H. The association between the idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis 1985;151:775-82.
(34.) Karmali MA, Martin P, Lim C, Cheung R, Arbus GS. Sensitive method for detecting low numbers of verotoxin-producing Escherichia coli in mixed cultures by use of colony sweeps and polymyxin extraction of verotoxin. J Clin Microbiol 1985;22:614-9.
Address for correspondence: G. Balakrish Nair, National Institute of Cholera and Enteric Diseases, P-33, CIT Road, Scheme XM, Beliaghata, Calcutta 700 010, India; fax: 91-33-350-5066; e-mail: firstname.lastname@example.org or email@example.com
Asis Khan, * Shinji Yamasaki, * ([dagger]) Toshio Sato, ([dagger]) Thandavarayan Ramamurthy, * Amit Pal, * Simanti Datta, * Nandini Roy Chowdhury, * Suresh Chandra Das, ([double dagger]) Asim Sikdar, ([double dagger]) Teizo Tsukamoto, ([section]) Sujit Kumar Bhattacharya, * Yoshifumi Takeda, ([paragraph]) and Gopinath Balakrish Nair * (#)
* National Institute of Cholera and Enteric Diseases, Calcutta, India; ([dagger]) Research Institute, International Medical Center of Japan, Shinjuku-ku, Tokyo, Japan; ([double dagger]) Indian Veterinary Research Institute, Belgachia, Calcutta, India; ([section]) Osaka Prefectural Public Health Institute, Osaka, Japan; ([paragraph]) National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan; and (#) International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh
|Printer friendly Cite/link Email Feedback|
|Author:||Nair, Gopinath Balakrish|
|Publication:||Emerging Infectious Diseases|
|Article Type:||Statistical Data Included|
|Date:||Jan 1, 2002|
|Previous Article:||Genetic characterization of the M RNA segment of Crimean Congo hemorrhagic fever virus strains, China. (Research).|
|Next Article:||Antimicrobial drug resistance in pathogens causing nosocomial infections at a University Hospital in Taiwan, 1981-1999. (Research).|